Molecular biological features of HPV type 16 infection and the risk of developing cervical squamous intraepithelial lesions and cervical cancer


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To determine the prevalence of HPV type 16 variants in the Russian Federation (Moscow and Moscow region) and investigate the association between mutations of human papillomavirus type 16 in the long control region (LCR), E6 and E7 genes and the probability of detecting high-grade CIN and cervical cancer. Material and methods. The study examined 63 cervical epithelial scrape samples positive for HPV type 16 that was confirmed by histological and cytological evidence. Results. Sixty-two of 63 samples belonged to lineage A, and only one sample was assigned to lineage D. Six substitutions for reference sequences were detected, of which four were in the LCR (G7193T, A7316C, T7496C, C24G), and 2 in the E6gene (T109C, T350G). C24G substitution was statistically significantly more common in samples from CIN2-3 and cervical cancer lesions (OR = 2.41, p = 0.04). Conclusions. This study for the first time reported the prevalence of HPV type 16 variants in the Russian Federation (Moscow and the Moscow Region) and showed that the population of HPV type 16 is quite monogenic and represented by the European lineage. Six substitutions were found in the examined fragment, and one of them (C24G) was statistically significantly more common in samples from CIN+ lesions. Substitutions A7316C, T109C and T350G showed a trend towards higher detection rates in samples showing CIN2-3.

Full Text

Restricted Access

About the authors

Marina Yu. Dmitryukova

Researcher at the CRI of Epidemiology of Rospotrebnadzor

Email: mdmitryukova@cmd.su
PhD (bio.sci.)

Lyubov’ I. Korolenkova

Blokhin Russian Cancer Research Center of Minzdrav of Russia

Email: l.korolenkova@mail.ru
MD, professor, senior researcher

Tat’yana N. Romanyuk

CRI of Epidemiology of Rospotrebnadzor

Email: tatiana.romaniuk@pcr.ms
junior researcher

Gul’nara V. Leshkina

CRI of Epidemiology of Rospotrebnadzor

Email: glyoshkina@yandex.ru
biologist

Ol’ga Yu. Shipulina

CRI of Epidemiology of Rospotrebnadzor

Email: olga.shipulina@pcr.ms
PhD, research team leader

German A. Shipulin

CRI of Epidemiology of Rospotrebnadzor

Email: german@pcr.ru
Ph.D., Head of the department of Molecular Diagnostics and Epidemiology

References

  1. Роговская С.И., Михеева И.В., Шипулина О.Ю., Минкина Г.Н., Подзолкова Н.М., Радзинский В.Е., Шипулин Г.А. Распространенность папилломавирусной инфекции в России. Эпидемиология и вакцинопрофилактика. 2012; 1: 25-33.
  2. Минкина Г.Н., Савичева А.М., Холл К., де Соза С.К., Шипицына Е.В., Колимиец Л.А. Распространенность различных типов вируса папилломы человека у женщин с цервикальной интраэпителиальной неоплазией тяжелой степени. Вопросы гинекологии, акушерства и перинатологии. 2013; 12(3): 32-7.
  3. Gravitt P. The known unknowns of HPV natural history J. Clin. Invest. 2011; 121(12): 4593-9. doi: 10.1172/JCI57149.
  4. Прилепская В.Н., Назарова Н.М., Мзарелуа Г.М., Фазуллин Л.З., Трофимов Д.Ю. ВПЧ-ассоциированные заболевания шейки матки - новое в диагностике. Акушерство и гинекология. 2015; 9: 20-6.
  5. Бурменская О.В., Назарова Н.М., Прилепская В.Н., Мзарелуа Г.М., Бестаева Н.В., Трофимов Д.Ю., Сухих Г.Т. Прогнозирование риска развития и прогрессирования цервикальных интраэпителиальных неоплазий, ассоциированных с папилломавирусной инфекцией. Акушерство и гинекология. 2016; 2: 92-8.
  6. Cornet I., Gheit T., Franceschi S., Vignat J., Burk R.D., Sylla B.S. et al. Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR. J. Virol. 2012; 86(12): 6855-61. doi: 10.1128/JVI.00483-12.
  7. Cornet I., Gheit T., Iannacone M.R., Vignat J., Burk R.D., Sylla B.S. et al. HPV16 genetic variation and the development of cervical cancer worldwide. Br. J. Cancer. 2013; 108(1): 240-4. doi: 10.1038/bjc.2012.508.
  8. Bernard H.U. Taxonomy and phylogeny of papillomaviruses: An overview and recent developments. Infect. Genet. Evol. 2013; 18: 357-61. doi: 10.1016/j.meegid.2013.03.011.
  9. Chang Y.J., Chen H.C., Pan M.H., Lee B.H., You S.L., Lin C.Y. et al. Intratypic variants of human papillomavirus type 16 and risk of cervical neoplasia in Taiwan. J. Med. Virol. 2013; 85(9): 1567-76. doi: 10.1002/jmv.23651.
  10. Sun Z., Lu Z., Liu J., Wang G., Zhou W., Yang L. et al. Genetic variations of E6 and long control region of human papillomavirus type 16 from patients with cer vical lesion in Liaoning, China. BMC Cancer. 2013; 13: 459. doi: 10.1186/1471-2407-13-459.
  11. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl. Acids Symp. Ser. 1999; 41: 95-8.
  12. Tamura K., Stecher G., Peterson D., Filipski A., Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol. Biol. Evol. 2013; 30(12): 2725-9. doi: 10.1093/molbev/mst197.
  13. Mirabello L., Yeager M., Cullen M., Boland J.F., Chen Z., Wentzensen N. et al. HPV16 sublineage associations with histology-specific cancer risk using HPV whole-genome sequences in 3200 women. J. Natl. Cancer Inst. 2017; 108(9). pii: djw100. doi: 10.1093/jnci/djw100.
  14. Park J.S., Shin S., Kim E.C., Kim J.E., Kim Y.B., Oh S. et al. Association of human papillomavirus type 16 and its genetic variants with cervical lesion in Korea. APMIS. 2016; 124(11): 950-7. doi: 10.1111/apm.12592.
  15. Marongiu L., Godi A., Parry J.V., Beddows S. Human papillomavirus type 16 long control region and E6 variants stratified by cervical disease stage. Infect. Genet. Evol. 2014; 26: 8-13. doi: 10.1016/j.meegid.2014.05.009.
  16. Zuna R.E., Moore W.E., Shanesmith R.P., Dunn S.T., Wang S.S., Schiffman M. et al. Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Int. J. Cancer. 2009; 125(11): 2609-13. doi: 10.1002/ijc.24706.
  17. Szostek S., Zawilinska B., Klimek M., Kosz-Vnenchak M. HPV16 E6 polymorphism and physical state of viral genome in relation to the risk of cervical cancer in women from the south of Poland. Acta Biochim. Pol. 2017; 64(1): 143-9. doi: 10.18388/abp.2016_1364.
  18. Sichero L., Sobrinho J.S., Villa L.L. Oncogenic potential diverge among human papillomavirus type 16 natural variants. Virology. 2012; 432(1): 127-32. doi: 10.1016/j.virol.2012.06.011.
  19. Ortiz-Ortiz J., Alarcon-Romero Ldel C., Jiménez-Lopez M.A., Garzon-Barrientos V.H., Calleja-Macias I., Barrera-Saldana H.A. et al. Association of human papillomavirus 16 E6 variants with cervical carcinoma and precursor lesions in women from Southern Mexico. Virol. J. 2015; 12: 29. doi: 10.1186/ s12985-015-0242-3.
  20. Gudlevicienė Ž., Stumbrytė A., Juknė G., Simanavičienė V., Žvirblienė A. Distribution of human papillomavirus type 16 variants in Lithuanian women with cervical cancer. Medicina (Kaunas). 2015; 51(6): 328-35. doi: 10.1016/j.medici.2015.11.005.
  21. Cornet I., Gheit T., Clifford G.M., Combes J.D., Dalstein V., Franceschi S. et al. Human papillomavirus type 16 E6 variants in France and risk of viral persistence. Infect. Agents Cancer. 2013; 8: 4. doi: 10.1186/1750-9378-8-4.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2019 Bionika Media